Heart rate score in remote monitoring: An additional tool for predicting outcomes in heart failure with reduced ejection fraction

被引:0
作者
Barradas, Maria Ines [1 ,2 ]
dos Santos, Ines Coutinho [1 ]
Duarte, Fabiana [1 ]
Monteiro, Andre Viveiros [1 ]
Tavares, Anabela [1 ]
Martins, Dinis [1 ]
机构
[1] Hosp Divino Espirito Santo Ponta Delgada, Ponta Delgada, Sao Miguel, Portugal
[2] Hosp Divino Espirito Santo Ponta Delgada, Ave D Manuel I, P-9500370 Ponta Delgada, Sao Miguel, Portugal
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2024年 / 47卷 / 04期
关键词
heart failure; heart rate score; remote monitoring;
D O I
10.1111/pace.14961
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heart rate score (HRS) >= 70% has been associated with arrhythmic events and mortality but these studies were not specific for heart failure (HF) patients. We hypothesized that HRS >= 70% obtained from remote monitoring (RM) is associated with HF hospitalizations and arrhythmic events in HF with reduced ejection fraction (HFrEF). Methods: HRS was calculated from RM in patients with HFrEF and ICD or CRT-D. Two groups were defined: HRS >= 70% (G1, n = 55) and HRS < 70% (G2, n = 48) Results: A total of 103 patients were included (64.4 +/- 13.04 years, 69.9% male, mean left ventricular ejection fraction (LVEF) 33.62 +/- 11.97% and FUP 61.7 +/- 38.87 months). The device was CRT-D in 59.2% and ICD in 40.8% and the majority (90.3%) had the device implanted in primary prevention. G1 patients were more frequently male (p = .017) and had more coronary disease (p = .035). HRS >= 70% was an independent predictor for unplanned HF hospitalizations (OR: 1.905 (95% CI: 1.328-3.649), p < .001)). The indication for device implantation (primary vs. secondary prevention), type of device, NYHA class, age, gender and LVEF were not independent predictors of the outcome. VF (4.9 +/- 20.0 G1 vs. 1.1 +/- 5.47 G2, p = .046) and VT episodes were more prevalent in G1 (3.1 +/- 8.93 G1 vs. 0.3 +/- 1.59 G2, p = .026), as well as appropriate device shocks (4.3 +/- 12.06 G1 vs. 0.3 +/- 1.49 G2, p = .023). There was no difference in inappropriate shocks or mortality outcomes between groups. Conclusion: HRS >= 70% obtained from RM was an independent predictor of HF hospitalizations and was associated with arrhythmic events with VT and VF episodes and appropriate device shocks in HFrEF patients.
引用
收藏
页码:490 / 495
页数:6
相关论文
共 50 条
  • [41] Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction
    Pandey, Ambarish
    Omar, Wally
    Ayers, Colby
    LaMonte, Michael
    Klein, Liviu
    Allen, Norrina B.
    Kuller, Lewis H.
    Greenland, Philip
    Eaton, Charles B.
    Gottdiener, John S.
    Lloyd-Jones, Donald M.
    Berry, Jarett D.
    [J]. CIRCULATION, 2018, 137 (17) : 1814 - +
  • [42] Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction
    Januzzi, James L., Jr.
    Ahmad, Tariq
    Mulder, Hillary
    Coles, Adrian
    Anstrom, Kevin J.
    Adams, Kirkwood F.
    Ezekowitz, Justin A.
    Fiuzat, Mona
    Houston-Miller, Nancy
    Mark, Daniel B.
    Pia, Ileana L.
    Passmore, Gayle
    Whellan, David J.
    Cooper, Lawton S.
    Leifer, Eric S.
    Desvigne-Nickens, Patrice
    Felker, G. Michael
    O'Connor, Christopher M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (09) : 1205 - 1217
  • [43] Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia
    Teng, Tiew-Hwa K.
    Tay, Wan Ting
    Richards, Arthur Mark
    Chew, Timothy Shi Ming
    Anand, Inder
    Ouwerkerk, Wouter
    Chandramouli, Chanchal
    Huang, Weiting
    Lawson, Claire A.
    Kadam, Umesh T.
    Yap, Jonathan
    Lim, Shirlynn
    Hung, Chung-Lieh
    MacDonald, Michael Ross
    Loh, Seet Yoong
    Shimizu, Wataru
    Tromp, Jasper
    Lam, Carolyn Su Ping
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (04): : E006962
  • [44] New Drugs and Devices in the Pipeline for Heart Failure with Reduced Ejection Fraction Versus Heart Failure with Preserved Ejection Fraction
    Raina A.
    Kanwar M.
    [J]. Current Heart Failure Reports, 2014, 11 (4) : 374 - 381
  • [45] Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction
    Mogensen, Ulrik M.
    Jhund, Pardeep S.
    Abraham, William T.
    Desai, Akshay S.
    Dickstein, Kenneth
    Packer, Milton
    Rouleau, Jean L.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    Kober, Lars
    McMurray, John J. V.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (20) : 2490 - 2500
  • [46] Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction
    Antonietta, Cicoira Maria
    Calvi, Emiliano
    Faggiano, Andrea
    Maffeis, Caterina
    Bosisio, Marco
    De Stefano, Marco
    Carugo, Stefano
    Faggiano, Pompilio
    [J]. CURRENT HEART FAILURE REPORTS, 2022, 19 (01) : 15 - 25
  • [47] Validation of a new score for outcome prediction in patients with heart failure with reduced ejection fraction
    Loiacono, Ferdinando
    Fragasso, Gabriele
    Calori, Giliola
    Alberti, Luca
    Marinosci, Giovanni
    Salerno, Anna
    Margonato, Alberto
    [J]. MINERVA CARDIOANGIOLOGICA, 2019, 67 (03): : 191 - 199
  • [48] Characteristics and Outcomes of Recovered Left Ventricular Ejection Fraction in Heart Failure Patients With Reduced Ejection Fraction.
    Kimishima, Yusuke
    Yoshihisa, Akiomi
    Ichijo, Yasuhiro
    Kiko, Takatoyo
    Sato, Yu
    Kanno, Yuki
    Takiguchi, Mai
    Yokokawa, Tetsuro
    Abe, Satoshi
    Misaka, Tomofumi
    Sato, Takamasa
    Oikawa, Masayoshi
    Kobayashi, Atsushi
    Yamaki, Takayoshi
    Kunii, Hiroyuki
    Ishida, Takafumi
    Takeishi, Yasuchika
    [J]. CIRCULATION, 2018, 138
  • [49] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [50] Ventricular arrhythmias in heart failure with reduced ejection fraction
    Voskoboinik, Aleksandr
    Moss, Joshua D.
    [J]. CURRENT OPINION IN CARDIOLOGY, 2020, 35 (03) : 282 - 288